Theory Paper IIDrNB Cardiology – Theory Notes
2D STRAIN IMAGING
ICORE PRINCIPLES OF 2D STRAIN (SPECKLE TRACKING ECHOCARDIOGRAPHY)
- Transition from Volume to Deformation: Two-dimensional (2D) Speckle Tracking Echocardiography (STE) directly quantifies active myocardial fiber deformation rather than global cavity volume change (Ejection Fraction), detecting subclinical systolic dysfunction long before LVEF declines.
- Physical Mechanism: Grayscale B-mode ultrasound interaction with myocardial tissue generates stable, natural acoustic backscatter interference patterns (“speckles”, 20 to 40 pixels in size). Software tracks the spatial displacement of these speckle kernels frame-by-frame throughout the cardiac cycle (angle-independent, unlike Tissue Doppler Imaging).
- Lagrangian Strain Formula: Strain (epsilon) represents the fractional or percentage change in length of a myocardial segment relative to its baseline end-diastolic length (L0): epsilon = [(L - L0) / L0] x 100 (note: the denominator is the original baseline length L0). Strain Rate (SR) is the temporal derivative of strain (speed of deformation per second, s-1).
- 17-Segment Polar Map (“Bull’s-Eye” Plot): Displays regional and Global Longitudinal Strain (GLS) across the basal (outer ring), mid-ventricular (middle ring), and apical (inner center) segments, alongside Mechanical Dispersion (standard deviation of time-to-peak longitudinal strain across 17 segments; normal <40 to 50 ms; prolonged in arrhythmogenic scar).
IICOMPONENTS OF MYOCARDIAL DEFORMATION
- Longitudinal Strain (Negative Value; Normal GLS: -18% to -22%, Lower Limit of Normal approx. -16% to -18% Depending on Vendor/Sex): Measures base-to-apex shortening from the apical 4-chamber, 2-chamber, and 3-chamber (long-axis) views. Because longitudinal fibers reside predominantly in the subendocardium (which has the highest wall stress and lowest coronary flow reserve), GLS is the earliest, most sensitive, and most reproducible marker of myocardial ischemia, toxicity, or fibrosis. (By EACVI/ASE convention, when comparing values, use absolute magnitude—e.g., a change from -20% to -14% is a reduction in GLS.)
- Circumferential Strain (Negative Value; Normal GCS: -20% to -26%): Measures systolic shortening along the circular short-axis perimeter (driven mainly by mid-wall circumferential fibers, which often compensate early in HFpEF or HCM to preserve LVEF despite reduced GLS).
- Radial Strain (Positive Value; Normal GRS: +35% to +50%): Measures transmural systolic wall thickening toward the LV cavity center on short-axis views (highest inter-observer variability).
- LV Rotation, Twist, and Torsion: Oblique subepicardial and subendocardial helical fibers produce counterclockwise apical rotation and clockwise basal rotation during systole (viewed from the apex), generating a wringing LV Twist (and during early isovolumic relaxation, rapid untwisting generates the intraventricular suction gradient for early diastolic filling).
| Cardiomyopathy / Disease State | Characteristic Bull’s-Eye Polar Map Pattern | Key Clinical / Diagnostic Significance |
|---|---|---|
| Cardiac Amyloidosis (ATTR / AL) | “Cherry-on-Top” (Relative Apical Sparing): Severely reduced basal/mid strain with preserved apical GLS (Apical-to-[Basal+Mid] ratio >=1.0) | Differentiates Amyloidosis from HCM, hypertensive LVH, and aortic stenosis |
| Hypertrophic Cardiomyopathy (HCM) | Marked focal strain reduction at the hypertrophied septum (or apical loss in Apical HCM — “reverse cherry”) | Correlates with CMR Late Gadolinium Enhancement (LGE) and predicts ventricular arrhythmias |
| Fabry Disease | Early focal reduction in the basal inferolateral (posterolateral) segment | Matches the classic site of early basal inferolateral LGE in Anderson-Fabry disease |
| Cancer Therapy Cardiotoxicity (CTRCD) | Diffuse global reduction; relative drop in GLS >15% from baseline with normal LVEF | Defines Mild Asymptomatic CTRCD in the 2022 ESC Cardio-Oncology Guidelines (SUCCOUR Trial) |
| Coronary Artery Disease (CAD) | Territorial segmental reduction (LAD, RCA, or LCx distribution) + Post-Systolic Shortening (PSS) | Identifies subclinical territory ischemia in NSTE-ACS or chronic coronary syndromes |
IIICLINICAL APPLICATIONS AND GUIDELINE INDICATIONS
- Cardio-Oncology (Class I Indication — 2022 ESC Cardio-Oncology Guidelines):
- Baseline and Serial Surveillance: Mandatory before and during Anthracycline or HER2-targeted (Trastuzumab) chemotherapy.
- Diagnostic Cut-off: A relative percentage reduction in GLS of greater than 15 percent from baseline (e.g., from -20% to -16.5%) in a patient with preserved LVEF (>=50%) defines Mild Asymptomatic Cancer Therapy-Related Cardiac Dysfunction (CTRCD) and guides initiation of cardioprotective ACEi/ARB and Beta-Blocker therapy (as evaluated in the randomized SUCCOUR Trial).
- Heart Failure Phenotyping (HFpEF and HFrEF):
- Occult Systolic Dysfunction in HFpEF: Over 50 percent of patients with HFpEF (LVEF >=50%) exhibit impaired GLS (absolute value less than 16 percent); impaired GLS <16% is a functional criterion in the HFA-PEFF diagnostic algorithm, and reduced Left Atrial Reservoir Strain (PALS <18 to 24%) is an increasingly used supportive marker.
- Superior Prognostication: Across the entire LVEF spectrum, GLS outperforms LVEF in predicting cardiovascular mortality and HF hospitalization.
- Ischemic Heart Disease (ACS and CCS):
- Post-Systolic Shortening (PSS): Ischemic myocardial segments continue to contract briefly after aortic valve closure (during isovolumic relaxation); a Post-Systolic Index (PSI) >20% is a sensitive marker of acute or chronic regional ischemia (“ischemic memory”).
- High-Risk NSTE-ACS: Resting territorial GLS impairment (and global GLS worse than -14% to -15%) identifies occult acute total coronary occlusion (e.g., LCx occlusion with non-diagnostic ECG) or Left Main / Triple-Vessel CAD prior to angiography.
- Valvular Heart Disease (Timing Early Intervention):
- Asymptomatic Severe Aortic Stenosis: Impaired GLS worse than -14.7% to -15.0% despite a normal LVEF (>60%) is associated with myocardial fibrosis and predicts worse post-AVR survival.
- Asymptomatic Severe Primary Mitral Regurgitation: Impaired LV GLS (worse than -18% to -20%), Right Ventricular Free-Wall Strain (worse than -20%), and LA Reservoir Strain (<22%) unmask early myocardial decompensation before LVEF drops below 60%.
IVTECHNICAL REQUIREMENTS, LIMITATIONS AND THE INDIAN CONTEXT
- Frame Rate and Image Quality: Optimal 2D speckle tracking requires high-quality grayscale endocardial/epicardial border definition at a frame rate of 40 to 80 frames per second (fps) (lower frame rates lose speckles; higher frame rates degrade spatial resolution).
- Load Dependency: Like LVEF, GLS is afterload-dependent (acute severe hypertension can reduce GLS; Myocardial Work Index [Pressure-Strain Loops] integrates cuff brachial systolic BP with GLS to provide a load-independent measure of Global Constructive and Wasted Work).
- Inter-Vendor Standardization: Although the EACVI/ASE Industry Task Force has reduced inter-vendor variability (between GE, Philips, Canon, and Siemens), serial follow-up in cardio-oncology or valvular disease must be performed on the same vendor platform (or using vendor-independent software such as TomTec).
- Application in the Indian Context: In Indian tertiary centers, GLS and LA Reservoir Strain are widely used for early detection of Diabetic and Hypertensive Subclinical Cardiomyopathy, risk-stratifying Rheumatic Mitral Stenosis (predicting atrial fibrillation and post-PTMC recovery), and correlating non-invasive territorial strain impairment with angiographic SYNTAX / Gensini scores in NSTE-ACS.
Key references
- Voigt JU, Pedrizzetti G, Lysyansky P, et al.: Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging, European Heart Journal – Cardiovascular Imaging, 2015.
- Lyon AR, López-Fernández T, Couch LS, et al.: 2022 ESC Guidelines on cardio-oncology, European Heart Journal, 2022.
- Thavendiranathan P, Negishi T, Somerset E, et al. (SUCCOUR Investigators): Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy, Journal of the American College of Cardiology, 2021.
meritmedscript.comDr. Sidhartha Mullapudi
